Latest Breaking News On - Jiangsu recbio technology co ltd - Page 1 : comparemela.com

Recbio And Rongsheng Biotech Signed a Strategic Cooperation Agreement On The New Adjuvant Vaccine Project

Recbio And Rongsheng Biotech Signed a Strategic Cooperation Agreement On The New Adjuvant Vaccine Project
lelezard.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from lelezard.com Daily Mail and Mail on Sunday newspapers.

Hong kongZhu shaorongLiu yongJiangsu recbio technology co ltdShanghai rongsheng biotech co ltdStock exchange of hong kongPrnewswire jiangsu recbio technology co ltdRecbio and rongsheng biotech signedRongsheng biotechPress releaseStock exchangeHong kong limited

Positive Results In The Interim Analysis Of The Clinical Trial Of Recbio s Novel Adjuvanted Recombinant Shingles Vaccine REC610 In The Philippines

Positive Results In The Interim Analysis Of The Clinical Trial Of Recbio s Novel Adjuvanted Recombinant Shingles Vaccine REC610 In The Philippines
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Hong kongAcosta cjsystematicGlaxosmithkline shingrixJiangsu recbio technology co ltdNational medical products administrationStock exchange of hong kongPublic healthPrnewswire jiangsu recbio technology co ltdInterim analysisMainland chinaPress releaseStock exchangeHong kong limited

Jiangsu Recbio Technology Co , Ltd Announces Positive Results in the Interim Analysis of the Clinical Trial of Recbio s Novel Adjuvanted Recombinant Shingles Vaccine REC610 in the Philippines

Jiangsu Recbio Technology Co., Ltd. announced that the novel adjuvanted recombinant shingles vaccine REC610 independently developed by the Company has recently achieved positive results in the interim.

Glaxosmithkline shingrixJiangsu recbio technology co ltdInterim analysisNational medical products administrationMainland china

Recbio appeared at the 14th China (Taizhou) International Pharmaceutical Fair

TAIZHOU, China, Oct. 24, 2023 /PRNewswire/ From October 19 to 22, the 14th China (Taizhou) International Pharmaceutical Fair, sponsored by the .

Hong kongLiu yongChina chamberInternational commerceChina taizhou international pharmaceutical fairBiomedical industry supply chain allianceChina research centerInternational centerZimbabwe national biotechnology authorityStock exchange of hong kongJiangsu recbio technology co ltdInternational pharmaceutical fairTaizhou municipal peopleJiangsu branchChina councilInternational trade

Recbio signed a strategic cooperation agreement with Zimbabwe National Biotechnology Administration and ICGEB China Regional Research Centre

On October 8, 2023, Dr. Deckster Tonny SAVADYE, CEO of Zimbabwe NBA, and Dr. Yang Yili, International Centre for Genetic Engineering and Biotechnology China Regional Research Centre(ICGEB), visited Recbio. Dr. SAVADYE and his team conducted an on-the-spot investigation of the manufacturing facilities for the COVID-19/Shingles vaccine and HPV vaccine at Recbio. Witnessed by the leaders of Taizhou Pharmaceutical High-tech Industrial Park, the three parties jointly signed a strategic cooperation ag

Hong kongStock exchange of hong kongJiangsu recbio technology co ltdPress releaseStock exchangeHong kong limitedHpv vaccineVaccine productionJiangsu recbio technology coStrategic cooperation agreement